Company profile for ONK Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ONK Therapeutics is dedicated to optimizing a next generation of off-the-shelf, dual-targeted NK cell therapies for patients with hematological malignancies and solid tumors. ONK Therapeutics is a privately held company, founded in 2015 based on the NK cell and apoptosis research of its founder Prof M O’Dwyer. MD and collaborators at National University of Ireland, Galway.The company’s unique approach harnesses the inna...
ONK Therapeutics is dedicated to optimizing a next generation of off-the-shelf, dual-targeted NK cell therapies for patients with hematological malignancies and solid tumors. ONK Therapeutics is a privately held company, founded in 2015 based on the NK cell and apoptosis research of its founder Prof M O’Dwyer. MD and collaborators at National University of Ireland, Galway.The company’s unique approach harnesses the innate biology of NK cells, which are optimized through its proprietary platform, introducing genetic modifications to improve both functionality and cytotoxicity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Ireland
Address
Address
Unit 1 an Coirneal Pier Road, Barna Co. Galway H91 V6KV
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/12/06/2791825/0/en/ONK-Therapeutics-and-NAYA-Biosciences-Announce-Research-Partnership-to-Advance-Combination-Therapy-of-Optimally-Engineered-Off-the-Shelf-Natural-Killer-Cell-Therapies-and-FLEX-NK-B.html

GLOBENEWSWIRE
06 Dec 2023

https://www.globenewswire.com/news-release/2023/06/27/2695003/0/en/European-Patent-Office-Grants-ONK-Therapeutics-Foundational-Patent-for-CISH-Knockout-in-NK-Cells-for-Use-in-Cancer-Therapies.html

GLOBENEWSWIRE
27 Jun 2023

https://www.globenewswire.com//news-release/2022/12/06/2567970/0/en/ONK-Therapeutics-Boosts-Drug-Development-Experience-and-Expands-US-Presence-with-the-Appointment-of-Bruce-McCreedy-Ph-D-as-Chief-Scientific-Officer.html

GLOBENEWSWIRE
06 Dec 2022

https://www.businesswire.com/news/home/20220829005049/en

BUSINESSWIRE
29 Aug 2022

https://www.prnewswire.com/news-releases/onk-therapeutics-brings-in-us-financial-experience-with-the-appointment-of-dr-allan-reine-as-independent-non-executive-director-301508197.html

PRNEWSWIRE
23 Mar 2022

https://www.thepharmaletter.com/article/intellia-and-onk-therapeutics-enter-collaboration

THEPHARMALETTER
16 Feb 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty